Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC Monograph User Fee Goals Document Beats Authorization To Finish Line

Executive Summary

While still awaiting the addition of OTC user fees to pending user fee authorization, and congressional approval of the overall package, FDA has developed guidelines closely tracking Sens. Isakson and Casey's OTC proposal. FDA plans a webinar to update industry on how OTC user fees would work.


Related Content

OTC Monograph User Fees Still On The Table, But Not In Legislation
FDA Gives Congress Reprieve On Deadline For Passing User Fee Bill
OTC Monograph User Fees Totaling $22m To $34m Floated In Senate Discussion Draft
OTC Monograph Woes No Surprise To FDA Commissioner Nominee Gottlieb
Sunscreen Industry Asks FDA For Flexibility Despite Guidances' Rigidity
FDA Asks Whether User Fees Will Repair OTC Monograph Process
OTC Monograph 'Disruption' Could Ride On PDUFA Reauthorization's Back





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts